BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29532870)

  • 21. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway.
    Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
    Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.
    Zheng M; Jiang YP; Chen W; Li KD; Liu X; Gao SY; Feng H; Wang SS; Jiang J; Ma XR; Cen X; Tang YJ; Chen Y; Lin YF; Tang YL; Liang XH
    Oncotarget; 2015 Mar; 6(9):6797-810. PubMed ID: 25762643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
    Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
    Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
    Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
    Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
    Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
    Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3.
    Wang J; Li P; Xu X; Zhang B; Zhang J
    Front Immunol; 2020; 11():907. PubMed ID: 32655542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
    Zhang D; Ni Z; Xu X; Xiao J
    Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
    Li X; Ding R; Han Z; Ma Z; Wang Y
    Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells-derived IL-6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK-STAT3 signalling.
    Liu C; Zhou J; Zhang S; Fu J; Li Y; Hao Y; Yuan J; Tang F; Ge W; He H; Chen Q
    Oral Dis; 2024 May; 30(4):2097-2109. PubMed ID: 37249062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.
    Ding J; Sun D; Xie P
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138758
    [No Abstract]   [Full Text] [Related]  

  • 35. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
    Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
    Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
    Li B; Lv Y; Zhang C; Xiang C
    J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
    Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
    Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
    Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
    Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.